Head-and-neck stages I and II extranodal non-Hodgkin's lymphomas: Real classification and selection for treatment modality

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 1, 2000, Pages 153-160

  Sasai, Keisuke ^a   Yamabe, Hirohiko ^a   Kokubo, Masaki ^a   Shibata, Toru ^a   Oya, Natsuo ^a   Nagata, Yaushi ^a   Hiraoka, Masahiro ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Extranodal; Non Hodgkin's lymphoma; REAL classification

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADNEXA DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER STAGING; DISEASE CLASSIFICATION; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NASOPHARYNX CANCER; NONHODGKIN LYMPHOMA; NOSE CAVITY CANCER; PARANASAL SINUS CANCER; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; T CELL LYMPHOMA; THYROID CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 0034255824     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00597-6     Document Type: Article

References (22)

1. Doll D.C. Extranodal lymphomas. Semin Oncol. 26:1999;249-250.
2. Miller T.P., Dahlberg S., Cassady J.R., et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med. 339:1998;21-26.
3. Isaacson P.G., Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology. 11:1987;445-462.
4. Isaacson P., Wright D.H. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer. 53:1984;2515-2524.
5. Pelstring R.J., Essell J.H., Kurtin P.J., et al. Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues. Am J Clin Pathol. 96:1991;738-745.
6. Harris N.L., Jaffe E.S., Stein H., et al. A revised European-American classification of lymphoid neoplasms A proposal from the International Lymphoma Study Group . Blood. 84:1994;1361-1392.
7. Tsutsui K., Shibamoto Y., Yamabe H., et al. A radiotherapeutic experience for localized extranodal non-Hodgkin's lymphoma Prognostic factors and re-evaluation of treatment modality . Radiother Oncol. 21:1991;83-90.
8. Yuen A., Jacobs C. Lymphomas of the head and neck. Semin Oncol. 26:1999;338-345.
9. Sasai K., Yamabe H., Haga H., et al. Non-Hodgkin's lymphoma of the thyroid. A clinical study of twenty-two cases. Acta Oncol. 35:1996;457-461.
10. Sasai K., Yamabe Y., Tsutsui K., et al. Primary testicular non-Hodgkin's lymphoma A clinical study and review of the literature . Am J Clin Oncol. 20:1997;59-62.
11. Perez C.A., Brady L.W. Overview. Perez C.A., Brady L.W. Principles and practice of radiation oncology. 2nd ed. 1992;1-63 J. B.Lippincott, Philadelphia.
12. Miller T.P., Dahlberg S., Weick J.K., et al. Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM A groupwide Southwest Oncology Group study . J Clin Oncol. 8:1990;1951-1958.
13. Jaffe ES. Histopathology and immunopathology. In: Magrath I, editor. The non-Hodgkin's lymphoma. 3rd ed. London: Arnold; Arnold; 1997. p. 79-131.
14. Kamath S.S., Marcus R.B., Lynch J.W., et al. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in Stage I and II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 44:1999;563-568.
15. Esik O., Ikeda H., Mukai K., et al. A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas. Radiother Oncol. 38:1996;13-18.
16. Reddy E.K., Bhatia P., Evans R.G. Primary orbital lymphomas. Int J Radiat Oncol Biol Phys. 15:1988;1239-1241.
17. Letschert J.G.J., Gonzalez D.G., Oskam J., et al. Results of radiotherapy in patients with stage I orbital non-Hodgkin's lymphoma. Radiother Oncol. 22:1991;36-44.
18. Cheng A.L., Su I.J., Chen Y.C., Uen W.C., Wang C.H. Characteristics clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma. Cancer. 72:1993;909-916.
19. Itami J., Itami M., Mikata A., et al. Non-Hodgkin's lymphoma confined to the nasal cavity Its relationship to the polymorhic reticulosis and results of radiation therapy . Int J Radiat Oncol Biol Phys. 20:1991;797-802.
20. Shikama N., Izuno I., Oguchi M., et al. Clinical stage IE primary lymphoma of the nasal cavity Radiation therapy and chemotherapy . Radiology. 204:1997;467-470.
21. Sakata K., Hareyama M., Ohuchi A., et al. Treatment of lethal midline granuloma type nasal T-cell lymphoma. Acta Oncol. 36:1997;307-311.
22. Liang R., Todd D., Chan T.K., et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol. 13:1995;666-670.